Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2022 | R21 | CA272351 | RFA-CA-21-003 | SOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE | Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy | Active |
2022 | R21 | CA261775 | CA21-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2023 | R33 | CA281802 | RFA-CA-22-002 | LABAER, JOSHUA | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck | Active |
2022 | R33 | CA269100 | CA21-004 | CHIU, BRIAN C-H | UNIVERSITY OF CHICAGO | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research | Active |
2021 | R33 | CA258016 | RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2022 | R21 | CA267245 | RFA-CA-21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2022 | R21 | CA269103 | CA21-003 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC. | Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout | Active |
2020 | R33 | CA247739 | RFA-CA-19-020 | MATRIX BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories For Targeting Extracellular Matrix | Active |
2023 | R61 | CA278398 | RFA-CA-22-001 | GAO, XIAOJING J | STANFORD UNIVERSITY | Program the Immune System against RAS-driven Cancer | Active |
2022 | R21 | CA272345 | RFA-CA-21-003 | KNOWLES, DAVID ARTHUR | NEW YORK GENOME CENTER | A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer | Active |
2021 | R21 | CA251043 | CA20-017 | HOSHIKA, SHUICHI | FOUNDATION FOR APPLIED MOLECULAR EVOLUTN | High Quality Proteins with Multiple Post Translational Modifications | Active |
2020 | R21 | CA251042 | RFA-CA-19-021 | GUPTA, GAUTAM | UNIVERSITY OF LOUISVILLE | Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens | Active |
2023 | R33 | CA272271 | RFA-CA-22-002 | CUNNINGHAM, BRIAN T | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2023 | R33 | CA278469 | RFA-CA-22-002 | JI, HANLEE P | STANFORD UNIVERSITY | Single cell modeling of cancer mutations | Active |
2023 | R33 | CA281602 | RFA-CA-22-002 | MEYER, KATHRYN D | DUKE UNIVERSITY | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2022 | R33 | CA272357 | RFA-CA-21-004 | PAN, TAO | UNIVERSITY OF CHICAGO | Transfer RNA sequencing and application to cancer research and clinics | Active |
2022 | R33 | CA272321 | RFA-CA-21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
2021 | R21 | CA261734 | CA20-019 | AKSAN, ALPTEKIN | UNIVERSITY OF MINNESOTA | Novel cryopreservation method for stabilization of manufactured therapeutic cells | Active |
2023 | R61 | CA278559 | RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis | Active |
2022 | R21 | CA261643 | RFA-CA-21-005 | TANG, SINDY KAM-YAN | STANFORD UNIVERSITY | A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy | Active |
2021 | R21 | CA263147 | CA20-017 | BHARGAVA, ROHIT | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | Spectroscopy Assisted Laser Microdissection | Active |
2020 | R21 | CA240185 | RFA-CA-19-019 | LI, WEI | TEXAS TECH UNIVERSITY | Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip | Active |
2021 | R43 | CA261362 | PAR-18-303 | ALLEN, JEFFREY KEITH | TUMORGEN, INC. | Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. | Active |
2023 | R61 | CA278459 | RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer | Active |
2021 | R33 | CA252158 | CA20-018 | ZENG, YONG | UNIVERSITY OF FLORIDA | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2022 | R21 | CA257942 | RFA-CA-21-003 | GIBBS, SUMMER LYNNE | OREGON HEALTH & SCIENCE UNIVERSITY | A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors | Active |
2021 | R33 | CA256086 | CA20-018 | JIANG, NING JENNY | UNIVERSITY OF PENNSYLVANIA | A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells | Active |
2023 | R61 | CA281795 | RFA-CA-22-001 | CAMPAGNOLA, PAUL J | UNIVERSITY OF WISCONSIN-MADISON | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. | Active |
2021 | R33 | CA256112 | CA20-018 | WEI, WEI | INSTITUTE FOR SYSTEMS BIOLOGY | Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy | Active |
2023 | R33 | CA278510 | RFA-CA-22-004 | DUNCAVAGE, ERIC J | WASHINGTON UNIVERSITY | A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer | Active |
2021 | R33 | CA261726 | CA20-018 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) | Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy | Active |
2020 | R21 | CA251052 | RFA-CA-19-019 | SHVETS, GENNADY | CORNELL UNIVERSITY | Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces | Active |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
2022 | R33 | CA259451 | RFA-CA-21-004 | NAEGLE, KRISTEN M | UNIVERSITY OF VIRGINIA | A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides | Active |
2020 | R21 | CA225493 | RFA-CA-19-019 | TEWARI, MUNEESH | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers | Active |
2023 | R33 | CA277820 | RFA-CA-22-002 | WEISSLEDER MD PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL | Bioorthogonal probe development for highly parallel in vivo imaging | Active |
2021 | R21 | CA255979 | CA20-017 | DIDENKO, VLADIMIR V | BAYLOR COLLEGE OF MEDICINE | In situ assay imaging nuclear RNA exosome activity for cancer studies | Active |
2020 | R33 | CA251037 | RFA-CA-19-020 | WANG, SIYUAN | YALE UNIVERSITY | Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer | Active |
2000 | R43 | CA086413 | PAR-99-101 | KOGON, ALEX A | BIOLINX, LLC | THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING | Complete |
2002 | R43 | CA097483 | PAR-01-105 | HANNA, MICHELLE M | RIBOMED BIOTECHNOLOGIES, INC. | RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER | Complete |
2006 | R33 | CA118591 | RFA-CA-06-002 | CLAWSON, GARY A. | PENNSYLVANIA STATE UNIV HERSHEY MED CTR | AN RNA SENSOR FOR DETECTION OF CIRCULATING TUMOR CELLS | Complete |
2009 | R21 | CA140068 | RFA-CA-08-006 | SHAPIRO, BENJAMIN | UNIV OF MARYLAND, COLLEGE PARK | SPATIAL, HIGH-ACCURACY, MULTIPLEXED MAPPING OF GENES IN HUMAN TISSUE SECTIONS | Complete |
2013 | R21 | CA173279 | RFA-CA-12-002 | SOPER, STEVEN ALLAN | UNIV OF NORTH CAROLINA CHAPEL HILL | ACUTE MYELOID LEUKEMIA: MRD ANALYSIS USING MODULAR UFLUIDICS AND UFLOW CYTOMETRY | Complete |
2016 | R33 | CA202900 | RFA-CA-15-003 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER | A GENETIC TOOLBOX FOR THE IDENTIFICATION AND INTERROGATION OF TUMOR CELLS OF ORIGIN, PROPAGATION, AND RECURRENCE FROM PATIENT-DERIVED ONCOGENIC DRIVERS | Complete |
2019 | R21 | CA236652 | RFA-CA-18-004 | SINGAMANENI, SRIKANTH | WASHINGTON UNIVERSITY | METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION | Complete |